{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04609566",
            "orgStudyIdInfo": {
                "id": "SGN35-033"
            },
            "secondaryIdInfos": [
                {
                    "id": "KEYNOTE-B81",
                    "type": "OTHER",
                    "domain": "Merck Sharp & Dohme LLC"
                },
                {
                    "id": "MK-3475-B81",
                    "type": "OTHER",
                    "domain": "Merck Sharp & Dohme LLC"
                }
            ],
            "organization": {
                "fullName": "Seagen Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors",
            "officialTitle": "A Phase 2 Study of Brentuximab Vedotin in Combination With Pembrolizumab in Subjects With Metastatic Solid Malignancies",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "brentuximab-vedotin-with-pembrolizumab-in-metastatic-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-01-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-10-23",
            "studyFirstSubmitQcDate": "2020-10-23",
            "studyFirstPostDateStruct": {
                "date": "2020-10-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Seagen Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Merck Sharp & Dohme LLC",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic).\n\nThe study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer.\n\nThis is a multi-cohort study."
        },
        "conditionsModule": {
            "conditions": [
                "Melanoma",
                "Non-small Cell Lung Cancer",
                "Squamous Cell Carcinoma of the Head and Neck"
            ],
            "keywords": [
                "Seattle Genetics"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 140,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Combination Therapy",
                    "type": "EXPERIMENTAL",
                    "description": "brentuximab vedotin + pembrolizumab",
                    "interventionNames": [
                        "Drug: brentuximab vedotin",
                        "Drug: pembrolizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "brentuximab vedotin",
                    "description": "1.8 mg/kg given into the vein (IV; intravenously) every 3 weeks",
                    "armGroupLabels": [
                        "Combination Therapy"
                    ],
                    "otherNames": [
                        "ADCETRIS"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "pembrolizumab",
                    "description": "200 mg given intravenously every 3 weeks",
                    "armGroupLabels": [
                        "Combination Therapy"
                    ],
                    "otherNames": [
                        "KEYTRUDA\u00ae"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Confirmed objective response rate (ORR) based on investigator assessment using Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) criteria",
                    "description": "Confirmed ORR per RECIST v1.1 is defined as the proportion of participants whose best overall response is a confirmed complete response (CR) or partial response (PR) per RECIST v1.1.",
                    "timeFrame": "Up to approximately 2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of response (DOR) based on investigator assessment using RECIST v1.1 criteria",
                    "description": "DOR per RECIST v1.1 is defined as the time from start of the first documentation of confirmed objective tumor response (CR or PR) per RECIST v1.1 to the first documentation of PD (per RECIST v1.1) or to death due to any cause, whichever comes first.",
                    "timeFrame": "Up to approximately 3 years"
                },
                {
                    "measure": "Progression-free survival (PFS) based on investigator assessment using RECIST v1.1 criteria",
                    "description": "PFS is defined as the time from start of study treatment to first documentation of objective tumor progression (PD per RECIST v1.1), or to death due to any cause, whichever comes first.",
                    "timeFrame": "Up to approximately 3 years"
                },
                {
                    "measure": "ORR per iRECIST by investigator assessment",
                    "description": "ORR per iRECIST is defined as the proportion of participants with confirmed CR or PR based on iRECIST guidelines",
                    "timeFrame": "Up to approximately 2 years"
                },
                {
                    "measure": "iDOR per iRECIST by investigator assessment",
                    "description": "DOR per iRECIST is defined as the time from first documentation of confirmed objective response (CR or PR) based on iRECIST guidelines by investigator assessment to the first documentation of confirmed objective tumor progression per iRECIST by investigator assessment, or to death due to any cause, whichever comes first.",
                    "timeFrame": "Up to approximately 3 years"
                },
                {
                    "measure": "iPFS per iRECIST by investigator assessment",
                    "description": "iPFS is defined as the time from start of study treatment to the first documentation of confirmed objective tumor progression per iRECIST by investigator assessment, treatment discontinuation following the unconfirmed progression or death due to any cause, whichever comes first.",
                    "timeFrame": "Up to approximately 3 years"
                },
                {
                    "measure": "Incidence of adverse events (AEs)",
                    "description": "National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 5.0. Analyses of AEs will be summarized with descriptive statistics.",
                    "timeFrame": "Up to approximately 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria\n\n* Participants must have\n\n  * Metastatic squamous or nonsquamous non-small cell lung cancer (NSCLC) (without known targetable EGFR, ALK, ROS1, or BRAF mutations) who either\n\n    * a) have not yet received frontline therapy for metastatic disease and without prior exposure to anti PD-1/PD-L1 or\n    * b) are relapsed/refractory with progression on anti PD-1/PD therapy.\n  * Relapsed/refractory metastatic cutaneous melanoma (regardless of mutation status) with progression on a PD-1 inhibitor\n  * Metastatic head and neck squamous cell carcinoma (HNSCC) who have not yet received frontline therapy for metastatic disease and without prior exposure to a PD-1/PD-L1 inhibitor.\n* Cohorts 1-4 only: Melanoma participants must be currently on PD-1 checkpoint inhibitor (CPI) therapy (e.g. nivolumab or pembrolizumab) or had their last dose of PD-1 CPI containing therapy as the last previous line of therapy within 90 days prior to enrollment; PD-1 CPI therapy must be the immediate prior line of treatment.\n* Cohorts 1-4 only: Participants must have progressed on treatment with an anti-PD-1 monoclonal antibody (mAb) administered either as monotherapy, or in combination with other CPIs or other therapies. PD-1 treatment progression is defined by meeting all of the following criteria.\n\n  * Have received at least 2 doses of an approved PD-1 inhibitor.\n  * Have demonstrated disease progression (PD) after a PD-1 inhibitor as defined by RECIST v1.1.\n\n    * Progressive disease has been documented within 90 days from the last dose of PD-1 inhibitor.\n    * Participants with melanoma will need iRECIST confirmation of progression with a second assessment at least four weeks after the initial date of progressive disease\n    * NSCLC participants on PD-1 inhibitor containing therapy for less than 90 days will need iRECIST confirmation of progression at least 4 weeks after the initial date of progressive disease\n* Tumor tissue sample obtained within 3 months prior to enrollment is required, and no systemic anticancer therapy given after the sample was obtained.\n* An Eastern Cooperative Oncology Group (ECOG) Performance Status score of equal or less than 1\n\nExclusion Criteria\n\n* Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.\n* Prior immunosuppressive chemotherapy, any immunotherapy other than a PD-1 inhibitor within 4 weeks of first study drug dose.\n* History of another malignancy within 3 years before the first dose of study drug or any evidence of residual disease from a previously diagnosed malignancy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Seagen Trial Information Support",
                    "role": "CONTACT",
                    "phone": "866-333-7436",
                    "email": "clinicaltrials@seagen.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Monitor",
                    "affiliation": "Seagen Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Arizona Oncology Associates, PC - HOPE",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85704",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stacey M Kimbell",
                            "role": "CONTACT",
                            "phone": "520-668-5678",
                            "email": "stacey.kimbell@usoncology.com"
                        },
                        {
                            "name": "Richard K Rosenberg",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Highlands Oncology Group",
                    "status": "RECRUITING",
                    "city": "Springdale",
                    "state": "Arkansas",
                    "zip": "72762",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bryan Handlos",
                            "role": "CONTACT",
                            "phone": "479-696-4269",
                            "email": "bhandlos@hogonc.com"
                        },
                        {
                            "name": "J. Thaddeus Beck",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.18674,
                        "lon": -94.12881
                    }
                },
                {
                    "facility": "cCARE - Northern",
                    "status": "COMPLETED",
                    "city": "Fresno",
                    "state": "California",
                    "zip": "93720",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.74773,
                        "lon": -119.77237
                    }
                },
                {
                    "facility": "The Angeles Clinic and Research Institute",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90025",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Teresa Mata",
                            "role": "CONTACT",
                            "phone": "310-231-2115",
                            "email": "tmata@theangelesclinic.org"
                        },
                        {
                            "name": "Inderjit Mehmi",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90048",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Inderjit Mehmi",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "California Cancer Associates for Research and Excellence Inc (cCARE)",
                    "status": "RECRUITING",
                    "city": "San Marcos",
                    "state": "California",
                    "zip": "92069",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edward F McClay",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.14337,
                        "lon": -117.16614
                    }
                },
                {
                    "facility": "University of Colorado Hospital / University of Colorado",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Theresa M Medina, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers - Aurora",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robert Jotte",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Memorial Healthcare System",
                    "status": "COMPLETED",
                    "city": "Hollywood",
                    "state": "Florida",
                    "zip": "33021",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.0112,
                        "lon": -80.14949
                    }
                },
                {
                    "facility": "Memorial Healthcare System",
                    "status": "COMPLETED",
                    "city": "Pembroke Pines",
                    "state": "Florida",
                    "zip": "33028",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.00315,
                        "lon": -80.22394
                    }
                },
                {
                    "facility": "Affiliated Oncologists, LLC",
                    "status": "RECRUITING",
                    "city": "Chicago Ridge",
                    "state": "Illinois",
                    "zip": "60415",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Angela Malone",
                            "role": "CONTACT",
                            "phone": "708-634-4637",
                            "email": "angela.malone@usoncology.com"
                        },
                        {
                            "name": "Rami Haddad",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.70142,
                        "lon": -87.77922
                    }
                },
                {
                    "facility": "Northwestern University",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ginny Keeling",
                            "role": "CONTACT",
                            "phone": "312-695-1365",
                            "email": "Ginny.Keeling@northwestern.edu"
                        },
                        {
                            "name": "Sunandana Chandra",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "University of Iowa Hospitals and Clinics",
                    "status": "RECRUITING",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yousef Zakharia",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "University of Kansas Cancer Center",
                    "status": "COMPLETED",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "Norton Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tabatha Matsumoto",
                            "role": "CONTACT",
                            "email": "tabatha.matsumoto@nortonhealthcare.org"
                        },
                        {
                            "name": "John Hamm",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Henry Ford Health System",
                    "status": "COMPLETED",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Minnesota Oncology Hematology P.A.",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55404",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sandeep Jain",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "University of Nebraska Medical Center",
                    "status": "RECRUITING",
                    "city": "Omaha",
                    "state": "Nebraska",
                    "zip": "68198-5090",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Omar Abughanimeh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.25626,
                        "lon": -95.94043
                    }
                },
                {
                    "facility": "Comprehensive Cancer Centers of Nevada",
                    "status": "COMPLETED",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89169",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "New York Oncology Hematology, P.C.",
                    "status": "RECRUITING",
                    "city": "Clifton Park",
                    "state": "New York",
                    "zip": "12065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ambri Cicchinelli",
                            "role": "CONTACT",
                            "phone": "518-489-2607",
                            "email": "ambri.cicchinelli@usoncology.com"
                        },
                        {
                            "name": "Stephen Wrzesinski",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.86563,
                        "lon": -73.77095
                    }
                },
                {
                    "facility": "Oncology Hematology Care",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45242",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nicole Clary",
                            "role": "CONTACT",
                            "phone": "800-710-4674",
                            "email": "Nicole.Clary1@usoncology.com"
                        },
                        {
                            "name": "Patrick J Ward",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Toledo Clinic Cancer Center",
                    "status": "COMPLETED",
                    "city": "Toledo",
                    "state": "Ohio",
                    "zip": "43623",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.66394,
                        "lon": -83.55521
                    }
                },
                {
                    "facility": "Willamette Valley Cancer Institute and Research Center",
                    "status": "RECRUITING",
                    "city": "Eugene",
                    "state": "Oregon",
                    "zip": "97401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christopher A Yasenchak",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.05207,
                        "lon": -123.08675
                    }
                },
                {
                    "facility": "Texas Oncology - Austin Central",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78731",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jeffrey Yorio",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "Texas Oncology - Baylor Sammons Cancer Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75246",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Charles Cowey",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Texas Oncology - Fort Worth 12th Avenue",
                    "status": "RECRUITING",
                    "city": "Fort Worth",
                    "state": "Texas",
                    "zip": "76104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nori Sullivan",
                            "role": "CONTACT",
                            "phone": "817-413-1760",
                            "email": "Nori.sullivan@usoncology.com"
                        },
                        {
                            "name": "Rachel L Theriault",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.72541,
                        "lon": -97.32085
                    }
                },
                {
                    "facility": "Oncology Consultants, PA",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julio Peguero",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Inova Schar Cancer Institute",
                    "status": "COMPLETED",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Virginia Oncology Associates",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Wendi Gobhardt",
                            "role": "CONTACT",
                            "email": "wendi.gobhardt@usoncology.com"
                        },
                        {
                            "name": "Graham T Watson, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                },
                {
                    "facility": "Virginia Commonwealth University Medical Center",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23298",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Johanna Biamonte",
                            "role": "CONTACT",
                            "phone": "804-628-1896",
                            "email": "jbiamonte@vcu.edu"
                        },
                        {
                            "name": "Erin Alesi",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                },
                {
                    "facility": "Oncology and Hematology Associates of Southwest Virginia",
                    "status": "RECRUITING",
                    "city": "Roanoke",
                    "state": "Virginia",
                    "zip": "24014",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amanda L. Gillespie-Twardy",
                            "role": "CONTACT",
                            "phone": "540-774-8660",
                            "email": "amanda.gillespietwardy@usoncology.com"
                        },
                        {
                            "name": "Amanda L. Gillespie-Twardy",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.27097,
                        "lon": -79.94143
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109-1023",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rebecca Wood",
                            "role": "CONTACT",
                            "phone": "206-606-6970",
                            "email": "rwood1@fredhutch.org"
                        },
                        {
                            "name": "Sylvia M Lee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "University of Ottawa / Ottawa General Hospital",
                    "status": "COMPLETED",
                    "city": "Ottawa",
                    "state": "Ontario",
                    "zip": "K1H 8L6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.41117,
                        "lon": -75.69812
                    }
                },
                {
                    "facility": "Jewish General Hospital",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H3T1E2",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Wilson H. Miller",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "McGill University Department of Oncology / McGill University Health Centre",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H4A 3J1",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Nathaniel Bouganim",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077195",
                    "term": "Squamous Cell Carcinoma of Head and Neck"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M1689",
                    "name": "Squamous Cell Carcinoma of Head and Neck",
                    "asFound": "Squamous Cell Carcinoma of the Head and Neck",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                },
                {
                    "id": "D000079963",
                    "term": "Brentuximab Vedotin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000922",
                    "term": "Immunotoxins"
                },
                {
                    "id": "D000018796",
                    "term": "Immunoconjugates"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2088",
                    "name": "Brentuximab Vedotin",
                    "asFound": "Polymorphism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4241",
                    "name": "Immunotoxins",
                    "relevance": "LOW"
                },
                {
                    "id": "M20855",
                    "name": "Immunoconjugates",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}